Microba Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 49
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $6.93M
Latest Deal Amount
  • Investors
  • 3

Microba General Information

Description

Developer of a microbial genomics technology intended to analyze personal gut microbiome. The company's technology uses microbial genomics to assists consumers to gain a deeper understanding of their personal microbiome including bacteria, archaea, fungi and protists at the species level, enabling customers to receive a detailed overview of the microorganisms inhabiting their gut and what they might be doing, which can provide insight into overall gut health.

Contact Information

Website
www.microba.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • GPO Box 469
  • Brisbane, Queensland 4001
  • Australia
+61 1300 000 000

Microba Timeline

2018201920202021
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Microba Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 16-Jun-2019 $6.93M 000.00 Completed Generating Revenue
3. Early Stage VC 01-Jun-2019 00.000 00.00 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Mar-2018 $7M $7M Completed Generating Revenue
1. Accelerator/Incubator 24-Mar-2017 $5.72K Completed Generating Revenue
To view Microba’s complete valuation and funding history, request access »

Microba Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a microbial genomics technology intended to analyze personal gut microbiome. The company's technology uses
Drug Discovery
Brisbane, Australia
49 As of 2020
000.00
00000000000 000.00

00000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut e
00000 0000000000 00000000
Bellevue, WA
000 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Microba Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000 Venture Capital-Backed Bellevue, WA 000 00000 0000000000 0 00000
You’re viewing 1 of 1 competitors. Get the full list »

Microba Executive Team (10)

Name Title Board Seat Contact Info
Blake Wills Chief Executive Officer
Luke Holtham President
James Heath Chief Financial Officer & Company Secretary
Yao Liu Chief Technology Officer
Drew Webb Chief Marketing Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Microba Board Members (8)

Name Representing Role Since
Caroline Popper MD Self Board Member 000 0000
Gene Tyson Microba Co-Founder & Board Member 000 0000
Hyungtae Kim Ph.D Microba Board Member 000 0000
Ian Frazer Microba Deputy Chairman 000 0000
Mark Capone Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Microba Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Microba Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Psomagen Corporation Minority 000 0000 000000 0
Alium Capital Management PE/Buyout Minority 000 0000 000000 0
ilab Accelerator/Incubator 000 0000 000000 0
To view Microba’s complete investors history, request access »